Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Rheumatoid Arthritis

  Free Subscription


Articles published in Rheumatol Int

Retrieve available abstracts of 144 articles:
HTML format
Text format



Single Articles


    February 2018
  1. HASEGAWA M, Sakai F, Konda N, Okabayashi A, et al
    CT assessment of axillary lymphadenopathy in patients with rheumatoid arthritis: association with disease activity and severity.
    Rheumatol Int. 2018 Feb 12. pii: 10.1007/s00296-018-3992.
    PubMed     Text format     Abstract available


  2. SIALA M, Rihl M, Sellami H, Znazen A, et al
    Detection of Shigella spp. nucleic acids in the synovial tissue of Tunisian rheumatoid arthritis patients and other forms of arthritis by quantitative real-time polymerase chain reaction.
    Rheumatol Int. 2018 Feb 5. pii: 10.1007/s00296-018-3939.
    PubMed     Text format     Abstract available


    January 2018
  3. LOPEZ-LONGO FJ, Seoane-Mato D, Martin-Martinez MA, Sanchez-Alonso F, et al
    Variability in the prescription of biological drugs in rheumatoid arthritis in Spain: a multilevel analysis.
    Rheumatol Int. 2018 Jan 24. pii: 10.1007/s00296-018-3933.
    PubMed     Text format     Abstract available


  4. KARAGULLE M, Kardes S, Karagulle MZ
    Long-term efficacy of spa therapy in patients with rheumatoid arthritis.
    Rheumatol Int. 2018 Jan 11. pii: 10.1007/s00296-017-3926.
    PubMed     Text format     Abstract available


  5. WON S, Cho SK, Kim D, Han M, et al
    Update on the prevalence and incidence of rheumatoid arthritis in Korea and an analysis of medical care and drug utilization.
    Rheumatol Int. 2018 Jan 4. pii: 10.1007/s00296-017-3925.
    PubMed     Text format     Abstract available


  6. TADA M, Inui K, Sugioka Y, Mamoto K, et al
    Abatacept might increase bone mineral density at femoral neck for patients with rheumatoid arthritis in clinical practice: AIRTIGHT study.
    Rheumatol Int. 2018 Jan 2. pii: 10.1007/s00296-017-3922.
    PubMed     Text format     Abstract available


    December 2017
  7. PEREZ-ROMAN DI, Ortiz-Haro AB, Ruiz-Medrano E, Contreras-Yanez I, et al
    Outcomes after rheumatoid arthritis patients complete their participation in a long-term observational study with tofacitinib combined with methotrexate: practical and ethical implications in vulnerable populations after tofacitinib discontinuation.
    Rheumatol Int. 2017 Dec 20. pii: 10.1007/s00296-017-3910.
    PubMed     Text format     Abstract available


  8. FORSYTH C, Kouvari M, D'Cunha NM, Georgousopoulou EN, et al
    The effects of the Mediterranean diet on rheumatoid arthritis prevention and treatment: a systematic review of human prospective studies.
    Rheumatol Int. 2017 Dec 18. pii: 10.1007/s00296-017-3912.
    PubMed     Text format     Abstract available


  9. SANTOS-MORENO P, Alvis-Zakzuk NJ, Villarreal-Peralta L, Carrasquilla-Sotomayor M, et al
    A comprehensive care program achieves high remission rates in rheumatoid arthritis in a middle-income setting. Experience of a Center of Excellence in Colombia.
    Rheumatol Int. 2017 Dec 16. pii: 10.1007/s00296-017-3903.
    PubMed     Text format     Abstract available


  10. OLIVIER N, Burger J, Joubert R, Lubbe M, et al
    Chronic disease list conditions in patients with rheumatoid arthritis in the private healthcare sector of South Africa.
    Rheumatol Int. 2017 Dec 12. pii: 10.1007/s00296-017-3907.
    PubMed     Text format     Abstract available


  11. GIANFRANCESCO MA, Yazdany J, Schmajuk G
    The impact of smoking on disease measures in rheumatoid arthritis: the need for appropriate adjustment of time-varying confounding.
    Rheumatol Int. 2017 Dec 5. pii: 10.1007/s00296-017-3902.
    PubMed     Text format     Abstract available


  12. KAMATA Y, Minota S
    Wide difference in biologics usage and expenditure for the treatment of patients with rheumatoid arthritis in each prefecture in Japan analyzed using "National Database of Health Insurance Claims and Specific Health Checkups of Japan".
    Rheumatol Int. 2017 Dec 5. pii: 10.1007/s00296-017-3900.
    PubMed     Text format     Abstract available


    November 2017
  13. DO ESPIRITO SANTO RC, Pompermayer MG, Bini RR, Olszewski V, et al
    Neuromuscular fatigue is weakly associated with perception of fatigue and function in patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Nov 27. pii: 10.1007/s00296-017-3894.
    PubMed     Text format     Abstract available


  14. BAGANZ L, Richter A, Kekow J, Bussmann A, et al
    Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohort.
    Rheumatol Int. 2017 Nov 16. doi: 10.1007/s00296-017-3870.
    PubMed     Text format     Abstract available


  15. AKYUZ G, Kenis-Coskun O
    The Efficacy of Tai Chi and Yoga in Rheumatoid Arthritis and Spondyloarthropathies: A narrative biomedical review.
    Rheumatol Int. 2017 Nov 4. doi: 10.1007/s00296-017-3867.
    PubMed     Text format     Abstract available


    October 2017
  16. UDACHKINA HV, Novikova DS, Popkova TV, Kirillova IG, et al
    Calcification of coronary arteries in early rheumatoid arthritis prior to anti-rheumatic therapy.
    Rheumatol Int. 2017 Oct 27. doi: 10.1007/s00296-017-3860.
    PubMed     Text format     Abstract available


  17. SKALKOU A, Manoli SM, Sachinidis A, Ntouros V, et al
    Pyoderma gangrenosum and pyogenic arthritis presenting as severe sepsis in a rheumatoid arthritis patient treated with golimumab.
    Rheumatol Int. 2017 Oct 26. doi: 10.1007/s00296-017-3861.
    PubMed     Text format     Abstract available


  18. TAN YK, Allen JC Jr, Lye WK, Chew LC, et al
    Greater rheumatoid arthritis joint improvement with more subjects achieving response across improvement categories using novel versus existing ultrasound methods.
    Rheumatol Int. 2017 Oct 20. doi: 10.1007/s00296-017-3857.
    PubMed     Text format     Abstract available


  19. LARKIN L, Gallagher S, Fraser A, Kennedy N, et al
    Community-based intervention to promote physical activity in rheumatoid arthritis (CIPPA-RA): a study protocol for a pilot randomised control trial.
    Rheumatol Int. 2017 Oct 17. doi: 10.1007/s00296-017-3850.
    PubMed     Text format     Abstract available


  20. LEE KE, Lee SS
    In reply to the letter to the Editor, "HAQ score is an independent predictor of sustained remission in patients with rheumatoid arthritis".
    Rheumatol Int. 2017 Oct 17. doi: 10.1007/s00296-017-3851.
    PubMed     Text format    


  21. WENG J, Wu H, Wang Z
    HAQ score is an independent predictor of sustained remission in patients with rheumatoid arthritis: methodological issues.
    Rheumatol Int. 2017 Oct 17. doi: 10.1007/s00296-017-3849.
    PubMed     Text format    


  22. KUME K, Amano K, Yamada S, Kanazawa T, et al
    Tofacitinib improves atherosclerosis despite up-regulating serum cholesterol in patients with active rheumatoid arthritis: a cohort study.
    Rheumatol Int. 2017 Oct 14. doi: 10.1007/s00296-017-3844.
    PubMed     Text format     Abstract available


  23. QUINTANA-DUQUE MA, Rondon-Herrera F, Calvo-Paramo E, Yunis JJ, et al
    The impact of smoking on disease activity, disability, and radiographic damage in rheumatoid arthritis: is cigarette protective?
    Rheumatol Int. 2017 Oct 11. doi: 10.1007/s00296-017-3845.
    PubMed     Text format     Abstract available


  24. BERNARDES M, Vieira T, Lucas R, Pereira J, et al
    Serum serotonin levels and bone in rheumatoid arthritis patients.
    Rheumatol Int. 2017 Oct 9. doi: 10.1007/s00296-017-3836.
    PubMed     Text format     Abstract available


    September 2017
  25. LEE KE, Choi SE, Xu H, Kang JH, et al
    HAQ score is an independent predictor of sustained remission in patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Sep 27. doi: 10.1007/s00296-017-3833.
    PubMed     Text format     Abstract available


  26. SCHIRMER M, Lion V
    Decline of rheumatologic care of nursing home residents with rheumatoid arthritis.
    Rheumatol Int. 2017 Sep 8. doi: 10.1007/s00296-017-3810.
    PubMed     Text format    


  27. SUGIMOTO N, Nakajima A, Inoue E, Shidara K, et al
    Incidence of comprehensive hospitalization due to infection, cardiovascular disease, fractures, and malignancies in patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Sep 7. doi: 10.1007/s00296-017-3811.
    PubMed     Text format     Abstract available


  28. SALAFFI F, Gerardi MC, Atzeni F, Batticciotto A, et al
    The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis.
    Rheumatol Int. 2017 Sep 5. doi: 10.1007/s00296-017-3792.
    PubMed     Text format     Abstract available


  29. YOON BY, Lee JH, Shin SY
    Discrepancy between subjective and objective measures of cognitive impairment in patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Sep 4. doi: 10.1007/s00296-017-3806.
    PubMed     Text format     Abstract available


    August 2017
  30. LAU CS, Gibofsky A, Damjanov N, Lula S, et al
    Down-titration of biologics for the treatment of rheumatoid arthritis: a systematic literature review.
    Rheumatol Int. 2017 Aug 29. doi: 10.1007/s00296-017-3780.
    PubMed     Text format     Abstract available


  31. LUQUE RAMOS A, Albrecht K, Zink A, Hoffmann F, et al
    Rheumatologic care of nursing home residents with rheumatoid arthritis: a comparison of the year before and after nursing home admission.
    Rheumatol Int. 2017 Aug 18. doi: 10.1007/s00296-017-3791.
    PubMed     Text format     Abstract available


  32. LI G, Zhao J, Li B, Ma J, et al
    Associations between CCL21 gene polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis.
    Rheumatol Int. 2017 Aug 10. doi: 10.1007/s00296-017-3784.
    PubMed     Text format     Abstract available


    July 2017
  33. KIM D, Cho SK, Choi CB, Choe JY, et al
    Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Jul 26. doi: 10.1007/s00296-017-3781.
    PubMed     Text format     Abstract available


  34. AZIZIEH FY, Al Jarallah K, Shehab D, Gupta R, et al
    Patterns of circulatory and peripheral blood mononuclear cytokines in rheumatoid arthritis.
    Rheumatol Int. 2017 Jul 19. doi: 10.1007/s00296-017-3774.
    PubMed     Text format     Abstract available


  35. HIRVONEN H, Kautiainen H, Moilanen E, Mikkelsson M, et al
    The effect of cryotherapy on total antioxidative capacity in patients with active seropositive rheumatoid arthritis.
    Rheumatol Int. 2017 Jul 11. doi: 10.1007/s00296-017-3771.
    PubMed     Text format     Abstract available


  36. TAN BE, Lim AL, Kan SL, Lim CH, et al
    Real-world clinical experience of biological disease modifying anti-rheumatic drugs in Malaysia rheumatoid arthritis patients.
    Rheumatol Int. 2017 Jul 10. doi: 10.1007/s00296-017-3772.
    PubMed     Text format     Abstract available


  37. GALARZA-DELGADO DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, et al
    Prevalence of comorbidities in Mexican mestizo patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Jul 5. doi: 10.1007/s00296-017-3769.
    PubMed     Text format     Abstract available


    June 2017
  38. GOH LL, Yong MY, See WQ, Chee EYW, et al
    NLRP1, PTPN22 and PADI4 gene polymorphisms and rheumatoid arthritis in ACPA-positive Singaporean Chinese.
    Rheumatol Int. 2017 Jun 26. doi: 10.1007/s00296-017-3762.
    PubMed     Text format     Abstract available


  39. MENA-VAZQUEZ N, Manrique-Arija S, Yunquera-Romero L, Urena-Garnica I, et al
    Adherence of rheumatoid arthritis patients to biologic disease-modifying antirheumatic drugs: a cross-sectional study.
    Rheumatol Int. 2017 Jun 19. doi: 10.1007/s00296-017-3758.
    PubMed     Text format     Abstract available


  40. HUSNI ME, Betts KA, Griffith J, Song Y, et al
    Benefit-risk trade-offs for treatment decisions in moderate-to-severe rheumatoid arthritis: focus on the patient perspective.
    Rheumatol Int. 2017 Jun 16. doi: 10.1007/s00296-017-3760.
    PubMed     Text format     Abstract available


  41. CARDENAS MJ, de la Fuente S, Castro-Villegas MC, Romero-Gomez M, et al
    Optimization of biological therapy in rheumatoid arthritis patients: outcomes from the CREATE registry after 2 years of follow-up.
    Rheumatol Int. 2017 Jun 9. doi: 10.1007/s00296-017-3757.
    PubMed     Text format     Abstract available


  42. PAVELKA K, Akkoc N, Al-Maini M, Zerbini CAF, et al
    Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access.
    Rheumatol Int. 2017 Jun 9. doi: 10.1007/s00296-017-3749.
    PubMed     Text format     Abstract available


    May 2017
  43. WEIJERS L, Baerwald C, Mennini FS, Rodriguez-Heredia JM, et al
    Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada.
    Rheumatol Int. 2017 May 30. doi: 10.1007/s00296-017-3739.
    PubMed     Text format     Abstract available


  44. RONDINA RG, de Mello RAF, Valim V, Lourenco RB, et al
    Discordance between clinical and imaging criteria: assessment by magnetic resonance imaging of the foot of patients with rheumatoid arthritis.
    Rheumatol Int. 2017 May 27. doi: 10.1007/s00296-017-3754.
    PubMed     Text format     Abstract available


  45. TZANETAKOS C, Tzioufas A, Goules A, Kourlaba G, et al
    Cost-utility analysis of certolizumab pegol in combination with methotrexate in patients with moderate-to-severe active rheumatoid arthritis in Greece.
    Rheumatol Int. 2017 May 18. doi: 10.1007/s00296-017-3736.
    PubMed     Text format     Abstract available


  46. MARRAS C, Monteagudo I, Salvador G, de Toro FJ, et al
    Identification of patients at risk of non-adherence to oral antirheumatic drugs in rheumatoid arthritis using the Compliance Questionnaire in Rheumatology: an ARCO sub-study.
    Rheumatol Int. 2017 May 17. doi: 10.1007/s00296-017-3737.
    PubMed     Text format     Abstract available


  47. SONG X, Lin Q
    Genomics, transcriptomics and proteomics to elucidate the pathogenesis of rheumatoid arthritis.
    Rheumatol Int. 2017 May 10. doi: 10.1007/s00296-017-3732.
    PubMed     Text format     Abstract available


  48. KABASAKAL Y, Kitapcioglu G, Karabulut G, Tezcan M, et al
    Criteria sets for primary Sjogren's syndrome are not adequate for those presenting with extraglandular organ involvements as their dominant clinical features.
    Rheumatol Int. 2017;37:675-684.
    PubMed     Text format     Abstract available


  49. LLORENTE I, Merino L, Ortiz AM, Escolano E, et al
    Anti-citrullinated protein antibodies are associated with decreased bone mineral density: baseline data from a register of early arthritis patients.
    Rheumatol Int. 2017;37:799-806.
    PubMed     Text format     Abstract available


  50. STREVENS BOLMGREN V, Olsson P, Wollmer P, Hesselstrand R, et al
    Respiratory symptoms are poor predictors of concomitant chronic obstructive pulmonary disease in patients with primary Sjogren's syndrome.
    Rheumatol Int. 2017;37:813-818.
    PubMed     Text format     Abstract available


    April 2017
  51. HUNTER TM, Boytsov NN, Zhang X, Schroeder K, et al
    Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014.
    Rheumatol Int. 2017 Apr 28. doi: 10.1007/s00296-017-3726.
    PubMed     Text format     Abstract available


  52. TADA M, Inui K, Sugioka Y, Mamoto K, et al
    Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study.
    Rheumatol Int. 2017 Apr 12. doi: 10.1007/s00296-017-3720.
    PubMed     Text format     Abstract available


  53. TAN BE, Lim AL, Kan SL, Lim CH, et al
    Management of rheumatoid arthritis in clinical practice using treat-to-target strategy: Where do we stand in the multi-ethnic Malaysia population?
    Rheumatol Int. 2017 Apr 7. doi: 10.1007/s00296-017-3705.
    PubMed     Text format     Abstract available


  54. DE MIGUEL E, Pecondon-Espanol A, Castano-Sanchez M, Corrales A, et al
    A reduced 12-joint ultrasound examination predicts lack of X-ray progression better than clinical remission criteria in patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Apr 7. doi: 10.1007/s00296-017-3714.
    PubMed     Text format     Abstract available


  55. NG WF, Miller A, Bowman SJ, Price EJ, et al
    Physical activity but not sedentary activity is reduced in primary Sjogren's syndrome.
    Rheumatol Int. 2017;37:623-631.
    PubMed     Text format     Abstract available


  56. GARCIA-MONTOYA L, Saenz-Tenorio CN, Janta I, Menarguez J, et al
    Hemophagocytic lymphohistiocytosis in a patient with Sjogren's syndrome: case report and review.
    Rheumatol Int. 2017;37:663-669.
    PubMed     Text format     Abstract available


    March 2017
  57. STOLT M, Suhonen R, Leino-Kilpi H
    Foot health in patients with rheumatoid arthritis-a scoping review.
    Rheumatol Int. 2017 Mar 21. doi: 10.1007/s00296-017-3699.
    PubMed     Text format     Abstract available


  58. EL-HENAWY AA, Hafez EA, Nabih N, Shalaby NM, et al
    Anti-Toxoplasma antibodies in Egyptian rheumatoid arthritis patients.
    Rheumatol Int. 2017 Mar 20. doi: 10.1007/s00296-017-3703.
    PubMed     Text format     Abstract available


  59. DE ANDRADE NP, da Silva Chakr RM, Xavier RM, Viecceli D, et al
    Long-term outcomes of treat-to-target strategy in established rheumatoid arthritis: a daily practice prospective cohort study.
    Rheumatol Int. 2017 Mar 14. doi: 10.1007/s00296-017-3695.
    PubMed     Text format     Abstract available


  60. KUUSALO L, Puolakka K, Kautiainen H, Karjalainen A, et al
    Patient-reported outcomes as predictors of remission in early rheumatoid arthritis patients treated with tight control treat-to-target approach.
    Rheumatol Int. 2017 Mar 13. doi: 10.1007/s00296-017-3692.
    PubMed     Text format     Abstract available


  61. BARRETT O, Abramovich E, Dreiher J, Novack V, et al
    Short- and long-term mortality due to sepsis in patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Mar 12. doi: 10.1007/s00296-017-3694.
    PubMed     Text format     Abstract available


  62. DIAZ-TORNE C, Moragues C, Toniolo E, Geli C, et al
    Impact of ultrasonography on treatment decision in rheumatoid arthritis: the IMPULSAR study.
    Rheumatol Int. 2017 Mar 3. doi: 10.1007/s00296-017-3689.
    PubMed     Text format     Abstract available


  63. NGEULEU A, Allali F, Medrare L, Madhi A, et al
    Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors.
    Rheumatol Int. 2017 Mar 3. doi: 10.1007/s00296-017-3665.
    PubMed     Text format     Abstract available


  64. LIANG SJ, Zheng QY, Yang YL, Yang Y, et al
    Use of etanercept to treat rheumatoid arthritis in an HIV-positive patient: a case-based review.
    Rheumatol Int. 2017 Mar 2. doi: 10.1007/s00296-017-3690.
    PubMed     Text format     Abstract available


  65. SCHENFELD J, Iles J, Trivedi M, Accortt NA, et al
    Dose relationship between oral glucocorticoids and tumor necrosis factor inhibitors and the risk of hospitalized infectious events among patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Mar 2. doi: 10.1007/s00296-017-3679.
    PubMed     Text format     Abstract available


  66. MCKENNA S, Donnelly A, Fraser A, Comber L, et al
    Does exercise impact on sleep for people who have rheumatoid arthritis? A systematic review.
    Rheumatol Int. 2017 Mar 1. doi: 10.1007/s00296-017-3681.
    PubMed     Text format     Abstract available


    February 2017
  67. ABUSHOUK AI, Ahmed H, Ismail A, Elmaraezy A, et al
    Safety and efficacy of ocrelizumab in rheumatoid arthritis patients with an inadequate response to methotrexate or tumor necrosis factor inhibitors: a systematic review and meta-analysis.
    Rheumatol Int. 2017 Feb 24. doi: 10.1007/s00296-017-3675.
    PubMed     Text format     Abstract available


  68. YU MB, Langridge WH
    The function of myeloid dendritic cells in rheumatoid arthritis.
    Rheumatol Int. 2017 Feb 24. doi: 10.1007/s00296-017-3671.
    PubMed     Text format     Abstract available


  69. SUNG YK, Cho SK, Kim D, Won S, et al
    Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab.
    Rheumatol Int. 2017 Feb 18. doi: 10.1007/s00296-017-3663.
    PubMed     Text format     Abstract available


  70. YUAN Y, Shao W, Li Y
    Associations between C677T and A1298C polymorphisms of MTHFR and susceptibility to rheumatoid arthritis: a systematic review and meta-analysis.
    Rheumatol Int. 2017 Feb 7. doi: 10.1007/s00296-017-3650.
    PubMed     Text format     Abstract available


  71. WABE N, Lee A, Wechalekar M, McWilliams L, et al
    Adherence to combination DMARD therapy and treatment outcomes in rheumatoid arthritis: a longitudinal study of new and existing DMARD users.
    Rheumatol Int. 2017 Feb 3. doi: 10.1007/s00296-017-3655.
    PubMed     Text format     Abstract available


    January 2017
  72. CUPPEN BV, Pardali K, Kraan MC, Marijnissen AC, et al
    Polymorphisms in the multidrug-resistance 1 gene related to glucocorticoid response in rheumatoid arthritis treatment.
    Rheumatol Int. 2017 Jan 28. doi: 10.1007/s00296-017-3653.
    PubMed     Text format     Abstract available


  73. SUNG YK, Cho SK, Kim D, Choi CB, et al
    Comparative effectiveness of treatment options after conventional DMARDs failure in rheumatoid arthritis.
    Rheumatol Int. 2017 Jan 28. doi: 10.1007/s00296-016-3649.
    PubMed     Text format     Abstract available


  74. BRANDSTETTER S, Riedelbeck G, Steinmann M, Ehrenstein B, et al
    Pain, social support and depressive symptoms in patients with rheumatoid arthritis: testing the stress-buffering hypothesis.
    Rheumatol Int. 2017 Jan 25. doi: 10.1007/s00296-017-3651.
    PubMed     Text format     Abstract available


  75. DEMMELMAIER I, Asenlof P, Bergman P, Nordgren B, et al
    Pain rather than self-reported sedentary time explains variation in perceived health and activity limitation in persons with rheumatoid arthritis: a cross sectional study in Sweden.
    Rheumatol Int. 2017 Jan 25. doi: 10.1007/s00296-016-3641.
    PubMed     Text format     Abstract available


  76. GAO L, Zhang XC, Li MM, Yuan JQ, et al
    Psychometric properties of the Chinese version of Arthritis Self-Efficacy Scale-8 (ASES-8) in a rheumatoid arthritis population.
    Rheumatol Int. 2017 Jan 6. doi: 10.1007/s00296-016-3640.
    PubMed     Text format     Abstract available


    December 2016
  77. VAN DEN HOEK J, Boshuizen HC, Roorda LD, Tijhuis GJ, et al
    Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study.
    Rheumatol Int. 2016 Dec 28. doi: 10.1007/s00296-016-3638.
    PubMed     Text format     Abstract available


  78. SCHIFF MH, Sadowski P
    Oral to subcutaneous methotrexate dose-conversion strategy in the treatment of rheumatoid arthritis.
    Rheumatol Int. 2016 Dec 23. doi: 10.1007/s00296-016-3621.
    PubMed     Text format     Abstract available


  79. KAWASHIMA H, Kagami SI, Kashiwakuma D, Takahashi K, et al
    Long-term use of biologic agents does not increase the risk of serious infections in elderly patients with rheumatoid arthritis.
    Rheumatol Int. 2016 Dec 20. doi: 10.1007/s00296-016-3631.
    PubMed     Text format     Abstract available


  80. AURRECOECHEA E, Llorca Diaz J, Diez Lizuain ML, McGwin G Jr, et al
    Gender-associated comorbidities in rheumatoid arthritis and their impact on outcome: data from GENIRA.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


    November 2016
  81. ACEBES C, McKay N, Ciechomska A, Alcorn N, et al
    Level of agreement between three-dimensional volumetric ultrasound and real-time conventional ultrasound in the assessment of synovitis, tenosynovitis and erosions in rheumatoid arthritis patients.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  82. KRASSELT M, Ivanov JP, Baerwald C, Seifert O, et al
    Low vaccination rates among patients with rheumatoid arthritis in a German outpatient clinic.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  83. WANG YC, Huang YP, Wang MT, Wang HI, et al
    Increased risk of rheumatoid arthritis in patients with migraine: a population-based, propensity score-matched cohort study.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  84. LAGE-HANSEN PR, Lindegaard H, Chrysidis S, Terslev L, et al
    The role of ultrasound in diagnosing rheumatoid arthritis, what do we know? An updated review.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


    October 2016
  85. ZLATKOVIC-SVENDA M, Rouse M, Radak-Perovic M, Stojanovic R, et al
    Adaptation and validation of the Rheumatoid Arthritis Quality of Life (RAQoL) questionnaire for use in Serbia.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  86. HATANO K, Kamishima T, Sutherland K, Kato M, et al
    A reliability study using computer-based analysis of finger joint space narrowing in rheumatoid arthritis patients.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  87. CARDENAS M, de la Fuente S, Castro-Villegas MC, Romero-Gomez M, et al
    Cost-effectiveness of clinical remission by treat to target strategy in established rheumatoid arthritis: results of the CREATE registry.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  88. SAITO K, Abe A, Kamishima T, Ishikawa H, et al
    Relationship between power Doppler grade and the pathological blood vessel features in long-standing rheumatoid arthritis.
    Rheumatol Int. 2016.
    PubMed     Text format    


    September 2016
  89. WONG PK
    Medication adherence in patients with rheumatoid arthritis: why do patients not take what we prescribe?
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  90. ALI AM, Vino S
    Genetic markers as therapeutic target in rheumatoid arthritis: A game changer in clinical therapy?
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  91. LEON L, Redondo M, Garcia-Vadillo A, Perez-Nieto MA, et al
    Influence of patient personality in the treatment of rheumatoid arthritis.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  92. BRUERA S, Barbo AG, Lopez-Olivo MA
    Use of medication reminders in patients with rheumatoid arthritis.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


    August 2016
  93. TACHECI I, Bradna P, Douda T, Bastecka D, et al
    Small intestinal injury in NSAID users suffering from rheumatoid arthritis or osteoarthritis.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  94. LOPEZ-GONZALEZ R, Seoane-Mato D, Perez-Vicente S, Martin-Martinez MA, et al
    Variability in the frequency of rheumatology consultations in patients with rheumatoid arthritis in Spain.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  95. GADEHOLT O, Wech T, Schuh S, Scharbatke E, et al
    Anti-CCP status determines the power Doppler oscillation pattern in rheumatoid arthritis: a prospective study.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


    July 2016
  96. ROBINSON C, Tsang L, Solomon A, Woodiwiss AJ, et al
    Omentin concentrations are independently associated with those of matrix metalloproteinase-3 in patients with mild but not severe rheumatoid arthritis.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  97. LABRECQUE JA, Kyle RP, Joseph L, Bernatsky S, et al
    Health-selective migration among patients with rheumatoid arthritis in Quebec: a cohort study using administrative data.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  98. MADSEN OR, Egsmose EM
    Fatigue, pain and patient global assessment responses to biological treatment are unpredictable, and poorly inter-connected in individual rheumatoid arthritis patients followed in the daily clinic.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  99. LEE YH, Bae SC
    Association of the ATIC 347 C/G polymorphism with responsiveness to and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  100. LUQUE RAMOS A, Hoffmann F, Callhoff J, Zink A, et al
    Influenza and pneumococcal vaccination in patients with rheumatoid arthritis in comparison with age- and sex-matched controls: results of a claims data analysis.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


    June 2016
  101. RASLAN HM, Attia HR, Salama I, Ibrahim MH, et al
    Association of PTPN22 1858C-->T polymorphism, HLA-DRB1 shared epitope and autoantibodies with rheumatoid arthritis.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  102. CASTILLO-ORTIZ JD, de Jesus Valdivia-Nuno J, Ramirez-Gomez A, Garagarza-Mariscal H, et al
    Fifteen-year trend in information on the World Wide Web for patients with rheumatoid arthritis: evolving, but opportunities for improvement remain.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  103. VALOR L, Martinez-Estupinan L, Janta I, Nieto JC, et al
    Ultrasound-detected joint inflammation and B cell count: related variables for rituximab-treated RA patients?
    Rheumatol Int. 2016;36:793-7.
    PubMed     Text format     Abstract available


  104. JANTA I, Moran J, Naredo E, Nieto JC, et al
    How does a cadaver model work for testing ultrasound diagnostic capability for rheumatic-like tendon damage?
    Rheumatol Int. 2016;36:863-9.
    PubMed     Text format     Abstract available


    May 2016
  105. PAMUK ON, Kalyoncu U, Aksu K, Omma A, et al
    A multicenter report of biologic agents for the treatment of secondary amyloidosis in Turkish rheumatoid arthritis and ankylosing spondylitis patients.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  106. KHANZADEH A, Habibagahi Z, Hosseini A, Amirghofran Z, et al
    Investigation of the human FCRL1, 2, and 4 gene expressions in patients with rheumatoid arthritis.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  107. JAMSHIDI AR, Banihashemi AT, Paragomi P, Hasanzadeh M, et al
    Anxiety and depression in rheumatoid arthritis: an epidemiologic survey and investigation of clinical correlates in Iranian population.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  108. YADLAPATI S, Efthimiou P
    Inadequate response or intolerability to oral methotrexate: Is it optimal to switch to subcutaneous methotrexate prior to considering therapy with biologics?
    Rheumatol Int. 2016;36:627-33.
    PubMed     Text format     Abstract available


    April 2016
  109. AHMADIANI S, Nikfar S, Karimi S, Jamshidi AR, et al
    Rituximab as first choice for patients with refractory rheumatoid arthritis: cost-effectiveness analysis in Iran based on a systematic review and meta-analysis.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  110. KUNWAR S, Devkota AR, Ghimire DK
    Fostamatinib, an oral spleen tyrosine kinase inhibitor, in the treatment of rheumatoid arthritis: a meta-analysis of randomized controlled trials.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  111. KUNWAR S, Dahal K, Sharma S
    Anti-IL-17 therapy in treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  112. MULLER R, Kull M, Polluste K, Aart A, et al
    The metabolic profile in early rheumatoid arthritis: a high prevalence of metabolic obesity.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  113. LEE YH, Bae SC
    Associations between PTPRC rs10919563 A/G and FCGR2A R131H polymorphisms and responsiveness to TNF blockers in rheumatoid arthritis: a meta-analysis.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  114. AKIYAMA M, Kaneko Y, Yamaoka K, Kondo H, et al
    Association of disease activity with acute exacerbation of interstitial lung disease during tocilizumab treatment in patients with rheumatoid arthritis: a retrospective, case-control study.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  115. MARTINEZ G, Gomez JA, Bang H, Martinez-Gamboa L, et al
    Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  116. KIM HL, Kim D, Jang EJ, Lee MY, et al
    Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthriti
    Rheumatol Int. 2016;36:505-13.
    PubMed     Text format     Abstract available


  117. ROSSINI M, Viapiana O, Adami S, Idolazzi L, et al
    Focal bone involvement in inflammatory arthritis: the role of IL17.
    Rheumatol Int. 2016;36:469-82.
    PubMed     Text format     Abstract available


    March 2016
  118. KIM D, Cho SK, Choi CB, Jun JB, et al
    Incidence and risk factors of fractures in patients with rheumatoid arthritis: an Asian prospective cohort study.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  119. GOSSEN N, Jacob L, Kostev K
    Second-line therapy with biological drugs in rheumatoid arthritis patients in German rheumatologist practices: a retrospective database analysis.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  120. COROMINAS H, Ortiz-Santamaria V, Castellvi I, Moreno M, et al
    Nailfold capillaroscopic findings in primary Sjogren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies.
    Rheumatol Int. 2016;36:365-9.
    PubMed     Text format     Abstract available


  121. CHEN J, Li S, Shi J, Zhang L, et al
    Serum progranulin irrelated with Breg cell levels, but elevated in RA patients, reflecting high disease activity.
    Rheumatol Int. 2016;36:359-64.
    PubMed     Text format     Abstract available


    February 2016
  122. ZHU A, Wang M, Zhou G, Zhang H, et al
    Fas/FasL, Bcl2 and Caspase-8 gene polymorphisms in Chinese patients with rheumatoid arthritis.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  123. KOCH MC, Pereira IA, Nobre LF, Neves FS, et al
    Computed tomography of pulmonary changes in rheumatoid arthritis: carcinoembryonic antigen (CEA) as a marker of airway disease.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  124. MEYER PW, Ally MM, Anderson R
    Reliable and cost-effective serodiagnosis of rheumatoid arthritis.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


    January 2016
  125. SUROWIEC I, Gjesdal CG, Jonsson G, Norheim KB, et al
    Metabolomics study of fatigue in patients with rheumatoid arthritis naive to biological treatment.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  126. CHUNG SW, Ha YJ, Kang EH, Lee YJ, et al
    The psychosocial status of the family members of rheumatoid arthritis patients in Korea.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  127. TAYLOR PC, Moore A, Vasilescu R, Alvir J, et al
    A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective.
    Rheumatol Int. 2016.
    PubMed     Text format     Abstract available


  128. LYU R, Govoni M, Ding Q, Black CM, et al
    Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
    Rheumatol Int. 2016;36:143-53.
    PubMed     Text format     Abstract available


  129. ICHIKAWA S, Kamishima T, Sutherland K, Okubo T, et al
    Performance of computer-based analysis using temporal subtraction to assess joint space narrowing progression in rheumatoid patients.
    Rheumatol Int. 2016;36:101-8.
    PubMed     Text format     Abstract available


  130. LU MC, Hsieh MC, Koo M, Lai NS, et al
    Risk of Sjogren's syndrome in Taiwanese female adults with irregular menstrual cycles: a population-based case-control study.
    Rheumatol Int. 2016;36:155-60.
    PubMed     Text format     Abstract available


    December 2015
  131. JANTA I, Valor L, De la Torre I, Martinez-Estupinan L, et al
    Ultrasound-detected activity in rheumatoid arthritis on methotrexate therapy: Which joints and tendons should be assessed to predict unstable remission?
    Rheumatol Int. 2015.
    PubMed     Text format     Abstract available


  132. ALETAHA D
    Management of rheumatoid arthritis: what happens and what does not happen in real life.
    Rheumatol Int. 2015.
    PubMed     Text format    


  133. KWIECINSKI J, Rothschild BM
    No rheumatoid arthritis in ancient Egypt: a reappraisal.
    Rheumatol Int. 2015.
    PubMed     Text format     Abstract available


    November 2015
  134. BUNJEVACKI V, Maksimovic N, Jekic B, Milic V, et al
    Polymorphisms of the eNOS gene are associated with disease activity in rheumatoid arthritis.
    Rheumatol Int. 2015.
    PubMed     Text format     Abstract available


  135. ZOLI A, Bosello S, Comerci G, Galiano N, et al
    Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks.
    Rheumatol Int. 2015.
    PubMed     Text format     Abstract available


  136. BEARNE LM, Byrne AM, Segrave H, White CM, et al
    Multidisciplinary team care for people with rheumatoid arthritis: a systematic review and meta-analysis.
    Rheumatol Int. 2015.
    PubMed     Text format     Abstract available


    August 2015
  137. WEI N, Chen Z, Xue Z, Zhu Y, et al
    Polymorphism of VEGF gene in susceptibility to chronic immune-mediated inflammatory diseases: a meta-analysis.
    Rheumatol Int. 2015;35:1351-60.
    PubMed     Text format     Abstract available


  138. ROBERTS SB, Wootton E, De Ferrari L, Albagha OM, et al
    Epigenetics of osteoarticular diseases: recent developments.
    Rheumatol Int. 2015;35:1293-305.
    PubMed     Text format     Abstract available


  139. HERNANDEZ-MOLINA G, Burkhardt AM, Lima G, Zlotnik A, et al
    Absence of salivary CCL28 in primary Sjogren's syndrome.
    Rheumatol Int. 2015;35:1431-4.
    PubMed     Text format     Abstract available


    April 2015
  140. HERNANDEZ-MOLINA G, Vargas-Alarcon G, Rodriguez-Perez JM, Martinez-Rodriguez N, et al
    High-resolution HLA analysis of primary and secondary Sjogren's syndrome: a common immunogenetic background in Mexican patients.
    Rheumatol Int. 2015;35:643-9.
    PubMed     Text format     Abstract available


  141. LIM MK, Shim TS, Park M, Lee SK, et al
    Heterozygote genotypes for PADI4_89 were protectively associated with susceptibility to tuberculosis in Koreans.
    Rheumatol Int. 2015;35:651-5.
    PubMed     Text format     Abstract available


    March 2015
  142. SHIFF NJ, Lix LM, Joseph L, Duffy C, et al
    The prevalence of systemic autoimmune rheumatic diseases in Canadian pediatric populations: administrative database estimates.
    Rheumatol Int. 2015;35:569-73.
    PubMed     Text format     Abstract available


    January 2015
  143. KATZ SJ, Leung S
    Teaching methotrexate self-injection with a web-based video maintains patient care while reducing healthcare resources: a pilot study.
    Rheumatol Int. 2015;35:93-6.
    PubMed     Text format     Abstract available


  144. NISHISHINYA MB, Pereda CA, Munoz-Fernandez S, Pego-Reigosa JM, et al
    Identification of lymphoma predictors in patients with primary Sjogren's syndrome: a systematic literature review and meta-analysis.
    Rheumatol Int. 2015;35:17-26.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: